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Abstract
Background: Use of supplements to aid performance is common practice amongst recreationally active individuals,
including those without a sufficient evidence base. This investigation sought to assess whether acute supplementation
with 8 g of citrulline malate (CM) (1.11: 1 ratio) would improve anaerobic performance.
Methods: A randomised double blind placebo control trial was employed, using a counterbalanced design. We
recruited recreationally active men and women to take part in an isokinetic chair protocol, based on German Volume
Training (GVT) whereby participants attempted to perform 10 sets of 10 repetitions against a force representing 70% of
their peak concentric force.
Results: The number of repetitions achieved over the course of the GVT was 94.0 ± 7.9 and 90.9 ± 13.9 for placebo and
CM respectively. There was no significant difference between the placebo and CM treatment for number of repetitions
(P = 0.33), isometric (P = 0.60), concentric (P = 0.38), or eccentric (P = 0.65) peak force following the GVT. Total muscle
soreness was significantly higher in the CM compared to the placebo treatment following the GVT protocol over 72 h
(P = 0.01); although this was not accompanied by a greater workload/number of repetitions in the CM group.
Conclusions: We conclude that an acute dose of CM does not significantly affect anaerobic performance using an
isokinetic chair in recreational active participants. Practical implications include precaution in recommending CM
supplementation. Coaches and athletes should be aware of the disparity between the chemical analyses of the
products reviewed in the present investigation versus the manufacturers’ claims.
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Background
Citrulline malate (CM) is an organic salt made up of the
non-essential amino acid L-citrulline and L-malic acid, an
intermediate in the citric acid cycle. The main dietary
source of citrulline is watermelon (Citrullus vulgaris),
while malic acid is common to apples (Malus pumila)
and grapes (Vitis vinifera). Initially CM was utilised as a
pharmaceutical drug (STIMOL©, BIOCODEX Gentilly,
France), for the treatment of patients suffering from
asthenia to mitigate recovery time following physical ac-
tivity [1]. However, the consistent search by athletes to
obtain a competitive advantage has led to the use of CM
as a potential ergogenic aid. Citrulline malate has been
purported to improve performance in both aerobic and
anaerobic exercise modalities via a variety of mechanisms
including: improved ammonia and lactic acid metabolism,
increased oxygen delivery capacity via increased vasodila-
tion and increased adenosine triphosphate production via
increases in kreb cycle intermediates [2, 3].
Citrulline malate has been shown to increase lactate
and ammonia clearance following exercise [4, 5]; this is
via acting as a nitrogen iron acceptor during the first
* Correspondence: a.chappell@shu.ac.uk
1Food and Nutrition group, Sheffield Business School, Sheffield Hallam
University, Stoddard Building, City Campus, Sheffield, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Chappell et al. Journal of the International Society of Sports Nutrition
 (2018) 15:42 
https://doi.org/10.1186/s12970-018-0245-8
stage of the urea cycle [6]. Supplementation may therefore
improve ammonia-buffering capabilities reducing acidosis
which occurs during intense exercise, as well as reducing
muscle soreness post exercise [7]. Secondly, citrulline can
be synthesised to arginine (ARG), a precursor to arginine
succinate (AS), and nitric oxygen (NO). The ensuing con-
version of AS to ARG by argininosuccinatelyase results in
the formation of fumarate an intermediate in the citric
acid cycle [8]. The conversion of citrulline to ARG via AS
is thought to be the rate limiting step in the NO cycle [9],
and supplementing with CM has been demonstrated
to increase blood ARG and ornithine [10, 11]. By way
of comparison, citrulline is more effective in increas-
ing plasma ARG, as a large proportion of ARG is lost
to splanchnic extraction, used as a substrate for urea-
genesis or degraded to yield ornithine and proline
[12]. Arginine itself is a known vasodilator and CM
indirectly increases vasodilation and production of nitrogen
oxygen synthase (NOS) in response to supplementation,
which may have a performance enhancing effect [11, 13].
Supplementation with CM has also been shown to
affect the rate of oxidative ATP production in response
to exercise [2]. This effect has been attributed to the
malic acid portion of the supplement as an intermediate
utilised in the citric acid cycle. Only a single study has
measured performance using citrulline without malate
which indicated a reduction in time to exhaustion fol-
lowing an incremental treadmill test to exhaustion [14].
It is not inconceivable that malate may have a potential
role in increasing aerobic exercise performance in com-
bination with citrulline, however it should be noted that
this hypothesis is predicated on a limited number of
studies. Citrulline malate’s potential ability to improve
skeletal muscle metabolism and/ or improve efficiency
would be expected to improve overall exercise perform-
ance and resistance to fatigue. A comprehensive review of
citrulline and NO metabolism is beyond the scope of this
paper, however interested readers are directed to reviews
by Curis et al. [3] and Besco et al. [15].
The ability to resist fatigue and consequently improve
performance/recovery would be of value to athletes.
Studies investigating the effect of CM on exercise per-
formance in humans and animals are not without prece-
dent and there are numerous papers suggesting the
positive effects of acute CM dosages between 3 and 12 g
on both aerobic and anaerobic performance related to
muscle damage, fatigue resistance and muscle soreness
[2, 14, 16–23]. However, a cause and effect relationship
between CM supplementation and exercise perform-
ance/recovery has yet to be established, positive findings
require corroboration, while a number of recent investiga-
tions have failed to demonstrate efficacy of CM [24–27].
Furthermore, a position stance from the International So-
ciety of Sports Nutrition on CM states it is unclear
whether adding these types of nutrients to energy drinks
or sports supplements provides an additive effect over
carbohydrate or caffeine commonly found within sport
supplement formulas [28]. There is therefore a need for
further testing of CM to justify inclusion in both resist-
ance and endurance training supplementation protocols.
The effect of CM has on muscular endurance and loss of
force utilising an isokinetic protocol is yet to be tested.
The aim of this investigation was to assess subjects’ ability
to resist fatigue during resistance exercise following an
acute dose of CM using a randomised double-blind pla-
cebo crossover trial with, the main outcome measures of:
total number of repetitions, muscle soreness, and blood
lactate. A German Volume Training (GVT) protocol was
selected as a means to elicit anaerobic fatigue because of
its repeated bout nature, and the difficulty of completing
the protocol at selected intensity. German Volume Train-
ing also provides a clear outcome measure associated with
measuring fatigue (e.g. number of complete repetitions) as
well as a real world similarity with programmes used by
resistance trainers likely to benefit from CM. We hypothe-
sise that CM will have an effect on exercise performance.
Methods
Study design
A randomised double-blind placebo cross-over design
was implemented (Fig. 1). Each subject reported to the
laboratory on three separate occasions 7 days apart. Sub-
jects were randomised with a counterbalanced approach
to either treatment or placebo using a random number
generator and concealment was performed by an inde-
pendent researcher (MB). Blinding was revealed on com-
pletion of the trial. On the first visit subjects were
familiarised with the experimental conditions, and the
visual analogue muscle soreness scale (VAS). During the
first visit, subjects performed the baseline maximum
strength determinations for isometric and dynamic con-
centric/eccentric contractions using an electromechanical
dynamometer (System 4 Pro, Biodex Medical Systems,
New York, USA). The dynamometer was set up to meas-
ure peak force (Fmax) generation for the knee extensor
muscles. The same warm up protocol was used for each
visit to the laboratory. Following a warm up, subjects per-
formed 3 isometric, concentric and eccentric maximum
voluntary contractions (MVC) per set, for 3 sets with
3 min rest between sets. The highest peak torque was
recorded for each contraction. The peak torque achieved
during the dynamic concentric contraction was used to
calculate the resistance used for the GVT protocol, set at
70% concentric Fmax. On the second and third visits, sub-
jects provided a blood sample and were supplemented
with either 8 g of CM (1.11: 1 ratio) or placebo, completed
a 24 h dietary recall and muscle soreness scale. After an
hour subjects provided an additional blood sample
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followed by performing the GVT protocol of 10 sets of 10
repetitions, with a one minute rest between sets. The total
number of repetitions was counted across each set and
failure was determined when a full range of motion could
no longer be completed. Following the GVT an additional
blood sample was taken from the subject after which ec-
centric, concentric and isometric strength were retested.
After the trial subjects completed the muscle soreness
scale as well as at 24, 48 and 72 h. The following week
subjects reported to the lab to complete the trial under
the opposite treatment condition.
Subject characteristics
Eighteen subjects (13 male, 5 female) volunteered to par-
ticipate in this study. Two males dropped out citing time
commitments, while one female dropped out for reasons
unrelated to the study. The subject characteristics are
displayed in Table 1. Subjects were recruited from Shef-
field Hallam University campus and gyms in the sur-
rounding area via posters, electronic advertising across
the university network and word of mouth. All subjects
were healthy, not suffering from any underlying health
conditions, free from injury, non-smokers and not cur-
rently using medication. Subjects were advised to follow
their normal dietary and supplementary regime for the
duration of their involvement in the trial (as both stop-
ping existing and beginning new supplements may have
interfered with results). Subjects were advised to avoid
any strenuous exercise 48 h pre and post visits to the la-
boratory. All subjects were following a structured resist-
ance training programme at least twice per week, for at
least 6 months. After explanation of all the experimental
procedures written consent was obtained from all partic-
ipants prior to taking part in the trial; which was approved
by the Sheffield Hallam University Food Research Ethics
committee.
Anthropometrics and muscle soreness scale
During the initial visit to the laboratory anthropometric
measurements were taken. Height and weight were assessed
using a stadiometer (Holtain, Crymych, United Kingdom),
and electronic scales (InBody 720, Biospace, Urbandale,
Iowa, USA). Body composition was established via bioelec-
trical impedance (InBody 720) and body mass index calcu-
lated based on kg/m2. Subjects were familiarised with the
VAS. A demonstration of how to palpate and score muscle
soreness was provided. Muscle soreness was scored
between 0 to 100 (0 indicated no pain, and 100 worst
pain imaginable) corresponding to four sites on the quad-
riceps: the Vastus Medialis, Vasus Lateralis, Retus Femoris
and Tensor Fasciae Latae. Muscle soreness was measured
pre and post GVT and subjects were provided with an
internet link to complete the VAS (Qualtics, Provo, Utah,
USA) at 24, 48 and 72 h after exercise. Subjects were
Fig. 1 Experimental Design. Each subject visited the laboratory one week apart. Subjects were supplemented with either 8 g of citrulline malate
or a placebo. The German Volume Training (GVT) was performed utilising an isokinetic single leg, leg extension protocol, 10 sets of 10 repetitions
at 80% 1 RM (obtained during baseline testing), with 1 min rest between sets
Table 1 Baseline subject characteristics
n - 15
Sex 11 M, 4 F
Age (yrs) 23.67 ± 2.41
Weight (kg) 75.15 ± 13.67
Height (m) 1.72 ± 0.10
Fat Mass (%) 14.91 ± 5.99
BMI (kg/m2) 25.16 ± 3.19
±, indicates standard deviation; BMI Body mass index, yrs. years, M male and
F female
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prompted by email and text message prompts to complete
the questionnaire.
Warm-up and cool-down
Prior to taking part in exercise, all subjects performed
the same warm-up. The warm-up, consisted of 10 min
of cycling at a rating of perceived exertion of 12 (Borg
scale 6–20), followed by 3 sets of 10 repetitions, of con-
centric only unilateral knee extensor exercises performed
on the dominant leg. Repetitions were performed over a
90° range of motion; from the furthest point a subject
could fully flex their working leg with a resistance of 20,
30, and 40 N m. An additional 5 min was then allocated
to subject to engage in unsupervised stretching. The
cool down consisted of 10 min of cycling at 8 on the
perceived exertion scale, and followed the muscle sore-
ness assessment.
Assessment of maximal force production
After a warm-up, unilateral quadriceps maximal volun-
tary torque was measured for isometric, concentric and
eccentric conditions. All testing was performed on the
subject’s dominant leg using an electronic dynamometer
(Biodex, System 4 Pro, Shrley, New York, USA). Isomet-
ric contractions were maintained for 5 s at 90° knee
flexion angle with 20 s rest between contractions. The
dynamometer movement arm was positioned with the
centre of rotation adjacent to the pivot point of the knee
(corresponding to the femoral condyles of the femur),
and adjusted to 90° using a goniometer. For concentric
and eccentric conditions a 90° (± 1°) range of motion
based on a subject’s ability to maximal flex and contract
their quadriceps was utilized. Limb weight was recorded
at the extremes of the subject’s range of motion. Sets of
3 concentric and eccentric contractions were performed
for 3 repetitions at 60°·second-1, with the eccentric con-
tractions performed in a passive manner. Three minutes
recovery was allocated between each test and the highest
Fmax recorded using a computer (Dell, Round Rock,
Texas, USA).
German volume training
Subjects were asked to refrain from strenuous exercise
48 h prior to and after each GVT session. All GVT ses-
sions were performed at the same time of day (± 1 h),
7 days apart, and under the same laboratory environ-
mental conditions (21 °C, 45–55% RH). Following the
warm-up the GVT was performed consisting of 10 sets
of concentric only single leg knee extensor exercises at
70% of the subjects concentric Fmax. Subjects performed
a maximum of 10 repetitions per set with 1 min recov-
ery between sets. Repetitions were performed over a 90°
range of motion and the set ended when the subject
could no longer complete a full range of motion. The
number of complete repetitions performed for each set
was recorded. Following the GVT maximal force pro-
duction and muscle soreness was reassessed. Subjects
were provided with verbal encouragement throughout
the GVT session. Subjects repeated the GVT protocol
under both treatment conditions.
Blood sampling and lactate analysis
Prior to the GVT exercise protocol, subjects rested for
10 min in a seated position. Blood samples were ob-
tained by way of finger prick using a lancet (Accu-chek,
Safe-T-Pro). A 20 цl blood sample was taken using a
capillary tube and added to an eppendorf containing
heperin and saline. Lactate was read immediately using a
Biosen C-line (EKF diagnostics, Ebendorfer, Germany).
A second blood sample was taken for lactate analysis
within 1 min of the completion of the GVT protocol.
Supplementation
Subjects were provided with either the treatment (8 g of
Citrulline Malate 1.11:1 ratio, 4.21 g citrulline, 3.79 g
malate (Bulk Powders, United Kingdom), or placebo (6 g
of Citric acid (Sigma-Aldrich, Dorset, United Kingdom).
Both conditions were provided in a mixture of 70 ml of
fruit cordial and 150 ml of water by RJ, or AA, and were
consumed within a 5 min under the supervision. Drinks
were prepared in advance by JG based on information
provided by MB, all authors were blinded for the dur-
ation of the trial period. The dosages and timing of the
drink provision were based on research, which show
citrulline peak levels occur 1 h after administration [10].
Dietary intake and analysis
Prior to the GVT, subjects were asked to recall all the
food and drink they consumed in the past 24 h. Subjects
were advised to refrain from starting any new dietary or
supplement regimes for the duration of their involvement
in the project and to consume similar foods the day before
and prior to visiting the laboratory. The contents of the
24 h recall were analysed using dietary analysis software
(Nutritics 2017, Dublin, Ireland). All results are expressed
as total grams and calories per kilogram of bodyweight.
Determination of supplement quality
The ratio of citrulline to malate within the dietary supple-
ment used in the trial was assessed using nuclear magnetic
resonance (NMR) spectroscopy. By way of comparison, 5
commercially available CM supplements with purported
2:1 ratios were also assessed from the following supple-
ment companies: Trade Ingredients (South Shields, United
Kingdom), Peak Supps (Bridgend, United Kingdom), Body-
building Warehouse™ (Manchester, United Kingdom),
MyProtein™ (Northwich, United Kingdom) Bulk Powders®
(Colchester, United Kingdom). The CM utilised by the
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participants in the present investigation was obtained from
Bulk Powders ®. The analysis was performed individually
on each of the five supplement powders in a blinded proto-
col and each powder was analysed in triplicate. A standard
NMR tube containing 100 mg of the citrulline malate
supplement powder was added to 1 mL of D2O (Fisher
Scientific, UK) for analysis. The tube was warmed to
40 °C and agitated to ensure complete dissolution of
the solid and therefore analysis of the total organic frac-
tion of the sample. Once the solid was completely dissolved,
the solution was allowed to cool to room temperature and
analysed on a Bruker Avance DPX-400 NMR spectrometer
operating at resonance frequencies of 400 MHz (1H) and
100 MHz (13C). Initially, all 1H and 13C NMR chemical en-
vironments in both citrulline and malic acid were unam-
biguously assigned using 1H, 1H–COSY, 13C, DEPT–135,
HSQC and HMBC experiments. The 1H NMR signals were
then integrated, with the signal resulting from H9 on malic
acid (at ∂ = 4.37 ppm) being calibrated as 1. The integration
values for the triplicate runs of all five supplements are
available as supplemental additional files (Additional file 1).
All possible comparisons of integral values between chem-
ical environments in citrulline and those in malate were
then performed. These results are summarised in as add-
itional files (Additional file 2). The mean nuclear ratios for
each individual replicate were then compiled into overall
mean and standard deviation values which represent the
citrulline:malate molar ratio calculated from 8 individual
data comparisons and three total experimental repeats.
Statistical analyses
An a priori power calculation was performed (G* power
version 3.1.9.2) based on the main outcome of number of
repetitions; in order to detect a difference between the
two-dependent means for the total number of repetitions
(matched pairs) with a power .80 and alpha 0.05 which de-
termined a sample size of 14 people for the crossover de-
sign utilised. We analysed differences in means between
lactate and total number of reps performed using a paired
samples t-test. Differences between reps performed over
sets during the GVT protocol and muscle soreness over
days was assessed using a repeated measures analysis of
variance (RMANOVA). Mauchly’s test of sphericity was
applied to the data to examine if sphericity was violated
and if this was the case the Greenhouse-Geisser estimate
was utilised. Post Hoc test were performed using pairwise
comparisons with Bonferroni adjustment. Difference be-
tween Fmax means between baseline, and both treatment
conditions was assessed using a one way ANOVA.
Results
Dietary intake
No side effects were reported and the supplement and pla-
cebo were well tolerated. The dietary intake from the 24-h
recall is presented in Table 2, there was no significant dif-
ference for macronutrient or energy intake between treat-
ment conditions. Protein and carbohydrate intakes were
within current ACSM/ISSN guidelines for strength and
power athletes (Protein, 1.6 to 2.0 g/kg bw, CHO 4 to
7 g/kg bw). Mean fat intake was similar to the ACSM/
ISSN guidance (20 to 30%). Mean alcohol intake over the
two treatment conditions was negligible (0.05 g/kg bw).
German volume training performance
Subjects’ GVT performance data is displayed in Fig. 2.
There was a significant difference in the number of repeti-
tions achieved over the ten sets (time P = 0.01). The par-
ticipant’s ability to complete a full set of 10-repetitions
progressively declined from set three. The mean number
of repetitions performed by the placebo and CM group
declined to 8.0 ± 0.6 by set ten. There was no significant
difference between the placebo and CM groups for repeti-
tion performance (P = 0.33) and no interaction between
treatment × sets (P = 0.34). The mean number of total
repetitions performed across the treatment conditions was
92.5 ± 11.5 from a possible 100 repetitions. There was no
significant difference (P = 0.34) in the total number of rep-
etitions performed between treatments (94.0 ± 7.9 Pla-
cebo, vs 90.9 ± 13.9 CM). Pairwise comparisons indicated
there was a significant difference (P < 0.05) in the number
of repetitions achieved during the GVT between sets 3, 5,
6, 7, 9 and 10. For more detail on pairwise comparisons,
see additional files (Additional file 3).
Maximal force production
Maximal isometric, concentric and eccentric force at
baseline and following each treatment condition is pre-
sented in Table 3. A total of 10 subjects completed the
Fmax follow-up tests due to technical issues. There was
no significant difference between isometric (P = 0.60),
Table 2 Subjects 24 h dietary intake preceding German volume training for both treatment arms
Citrulline Malate Placebo P Value Mean Intake
Protein g/kg bw 2.7 ± 3.0 3.0 ± 2.4 0.39 2.9 ± 2.58
Carbohydrate g/kg bw 5.5 ± 4.9 6.6 ± 4.2 0.30 6.1 ± 4.4
Fat g/kg bw 3.1 ± 4.1 1.1 ± 0.6 0.07 2.1 ± 2.6
Total Energy kcal/kg bw 26.9 ± 6.6 27.6 ± 9.5 0.81 27.2 ± 8.4
±, indicates standard deviation; g/kg bw for macronutrient and kcal/kg bw for total energy intake scaled for bodyweight. Results analysed using student t-test
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concentric (P = 0.38) and eccentric (P = 0.65) Fmax fol-
lowing the GVT with either the placebo or CM treat-
ment. Moreover, no significant differences were noted in
the decline of isometric (CM: − 5.61 ± 47.25 N, Placebo:
18.89 ± 50.64 N, P = 0.25), concentric (CM: − 13.59 ±
56.68 N, Placebo: − 10.38 ± 56.57, P = 0.76), or eccentric
(CM: − 4.02 ± 51.17 N, Placebo: − 2.19 ± 50.65, P = 0.64)
Fmax (Table 4).
Blood lactate and delayed onset muscle soreness
Blood lactate concentrations measured pre GVT in the
Placebo and CM treatment were 1.45 ± 0.54 mmol/l and
1.69 ± 1.07 mmol/l respectively (P = 0.53). Following the
GVT protocol blood lactate increased to 4.16 ± 1.34 mmol/l
and 4.31 ± 1.31 mmol/l in the placebo and CM treatment
groups respectively (P = 0.72). The difference between pre
and post GVT blood lactate concentrations was calculated.
There was no difference (P = 0.48) between treatment con-
ditions (CM: 2.51 ± 1.53 mmol/l vs Placebo 2.87 ±
1.25 mmol/l). The effect of the GVT protocol on the sum
of total muscle soreness is displayed in Fig. 3. Muscle sore-
ness increased significantly over time (P < 0.01). Muscle
soreness increased immediately following the GVT protocol
and peaked at 24 h post exercise before declining by 72 h
period in both treatment groups. Pairwise comparisons
indicated soreness was significantly higher (p < 0.05) post
GVT and at 24 and 48 h, compared to the pre and 72 h
measurement (see Additional file 4). Total muscle soreness
over 72 h was significantly higher in the CM compared to
the Placebo treatment following the GVT training protocol
(P < 0.01). There was also a significant interaction between
treatment × soreness (P = 0.01). There was a significant dif-
ference in soreness ratings between the four muscle sites
palpated and assessed (P = 0.01). Analysis of specific muscle
site soreness indicated that the Vastus Medialis and the Vas-
tus Lateralis sites had consistently higher soreness ratings
throughout the trial compared with the Tensor Fasciae and
Rectus Femoris. Site specific VAS scores are available as an
additional file (Additional file 5).
Supplement analysis
The ratio of citrulline to malate measured in formulas
from different supplement companies with purported
2:1 ratios is displayed in Table 4. The CM supplement
used in the present investigation was supplied by Bulk
Powders® (Colchester, United Kingdom).
Discussion
We measured the effects of an acute 8 g dose of CM on
anaerobic performance/recovery using a GVT protocol
performed with an isokinetic chair in 15 subjects. The
acute dose of CM was administered one hour before
resistance training and did not significantly affect the
number of repetitions performed. This finding is con-
trary to similar studies, which found significant effects
from CM of the same dose [18, 19, 22]. In the present
investigation not only did the CM not attenuate the
marker of muscle soreness, but was associated with
greater soreness over the 72 h following exercise. More-
over, CM supplementation had no effect on blood lactate
concentrations following exercise. More recently, a trial
using a lower dose (6 g versus 8 g in the present investi-
gation) did not find any significant difference in any
dependent variables (including number of repetitions,
soreness, creatinine kinase levels and rating of perceived
exertion [25]. The present investigation also included
chemical analysis of the supplement used, which con-
cluded that the ratio of citrulline to malate was not
equivalent to the ratio stated by the manufacturer. Ana-
lysis suggests that the supplement contained just over
half the manufacturers stated dose of citrulline. Subse-
quent analysis of four additional commercially available
CM products, with a purported ratio of 2:1 (citrulline to
malate), shows that only one of these products had a
value close to the ratio stated by the manufacturers. This
is the first study, to our knowledge, to report the citrul-
line to malate ratio of a number of these supplements.
Although no difference was found for the main out-
come measure of repetitions, this design utilised an
Fig. 2 Mean Number of Repetitions Performed Per Set, with and
without Citrulline Malate Supplementation. Means were compared
using a repeated measures ANOVA, No significant difference was
detected between placebo and treatment P = 0.33, or treatment ×
sets P = 0.34. Repetitions significantly decreased over the ten sets P
= 0.01, e.g. subjects performed significantly less repetitions as they
progressed from set 1 to set 10 irrespective of treatment. Error bars
indicate standard error of the mean
Table 3 Maximal voluntary force production (N) at baseline and
following German volume training with either citrulline malate
or placebo
Baseline Citrulline Malate Placebo P Value
Isometric 208.2 ± 70.9 213.1 ± 80.3 206.2 ± 55.4 0.37
Concentric 142.4 ± 60.0 144.6 ± 62.1 159.2 ± 53.8 0.96
Eccentric 142.6 ± 77.1 135.8 ± 77.7 146.9 ± 66.9 0.99
±, indicates standard deviation. Means compared using a one-way ANOVA.
Results based on n - 10
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acute dose of CM and our data supports the findings of
recent investigations of resistance training performance
[25–27]. In each instance, a 6 to 8 g acute dose CM had
no effect on the number of repetitions achieved when
performing either upper or lower-body resistance exer-
cises compared to a placebo. By way of comparison, our
results are in contrast to other trials, which investigated
the effects of 8 g of acutely administered CM on the
number of repetitions achieved during both upper and
lower body exercise challenges [17, 18, 22]. It is however
worth pointing out that there are differences in the study
design, subject populations and mode of delivery be-
tween the present investigation and previous trials. The
present study and utilised a single-leg leg extension ex-
ercise, and although the subjects had some experience
with weight training the lack of familiarisation with the
isokinetic chair protocol may have influenced perform-
ance. We did accommodate for this however with our
counterbalanced design to negate any potential training
effect. It is plausible that CM may be more effective in
highly trained resistance trained populations. Differences
between fixed range of motion single joint exercises and
multi joint exercises employed in the different modalities
may have also resulted in the differences between this
study and previous trials findings. Although most ath-
letes will likely utilise free weight exercises in their train-
ing, the use of an isokinetic chair should be considered a
strength for its ability to deliver a consistent resistance
and standardisation across subjects.
Citrulline malate supplementation also had no effect
on the loss of force production and similar results were
noted by Martinez-Sanchez et al. [29], who found CM
was ineffective at preserving mean average force, peak
average force, or the decline in force production follow-
ing 8 sets of 8 half squats at 80% RM. The addition of
pomegranate juice containing ellagitannins however did
improve efficacy of the supplement [29]. Similarly, a re-
cent trial of a pre-workout supplement which compared
3 supplements; one containing BCAA’s, creatine, caffeine
and a 6 g dose of CM; one containing the same (but
without caffeine); and a placebo, failed to find any sig-
nificant improvement in loss of force during resistance
exercise from either supplement [30]. In contrast, CM
was effective in retaining muscle power measured by
counter measure jump in runners following a marathon
Martinez-Sanchez et al. [29] but not at retaining peak
power following maximal cycle sprints in well-trained cy-
clists, [20] these results suggest the effectiveness of CM to
retain power may be dependent exercise modality.
The GVT protocol utilised was relatively novel and al-
though it isn’t generally employed by athletic populations
such programmes are common amongst recreational
weight trainers likely to utilise and benefit from CM. The
protocol effectively reduces the number of repetitions
achieved across set and was effective at increasing lactate
concentrations in both the placebo and CM group. Citrul-
line malate however had no effect on lactate buffering
when compared to a placebo which might explain the
lack of difference in repetition performance between
the placebo and CM group. We did not measure citrulline,
arginine or NOS, following supplementation. However,
previous investigations have demonstrated there is a dose
response relationship between ingestion of CM and
Table 4 Ratios of citrulline to malate from different supplement companies with purported 2:1 ratios measured by nuclear magnetic
resonance spectroscopy
Company Citrulline: Malate Ratio Citrulline: Malate g / per 8 g dose
TRADE INGREDIENTS 1.92: 1 ± 0.10 5.26: 2.74
PEAK SUPPS 1.62: 1 ± 0.12 4.95: 3.05
BODYBUILDING WAREHOUSE™ 1.57: 1 ± 0.15 4.88: 3.12
MYPROTEIN™ 1.51: 1 ± 0.04 4.81: 3.19
BULK POWDERS®a 1.11: 1 ± 0.02 4.21: 3.79
±, indicates standard deviation; TRADE INGREDIENTS (South Shields, United Kingdom), PEAK SUPPS (Bridgend, United Kingdom), BODYBUILDING WAREHOUSE™
(Manchester, United Kingdom), MYPROTEIN™ (Northwich, United Kingdom) BULK POWDERS® (Colchester, United Kingdom)
aThe citrulline malate used in the present investigation was obtained from BULK POWDERS®
Fig. 3 Quadriceps Muscle Soreness Over Time following German
Volume Training with, and without Citrulline Malate. Means were
compared using a repeated measures ANOVA. There was a
significant difference between treatment, time and treatment × time
P < 0.01. i.e. significantly more muscle soreness was observed in the
citrulline malate treatment compared to the placebo treatment over
time. A Post Hoc was performed using a pairwise comparison and
Bonferroni adjustment. * symbols indicate significant difference
between pre and 72 h time point with. Error bars indicate standard
error of the mean, h, hours
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plasma citrulline, ornithine, arginine and glutamine 1 h
after consumption [10, 20, 29]. L-arginine is the key sub-
strate in NO synthesis and it has been suggested that CM
may increase NO synthesis indirectly: and subsequently
muscle waste-product clearance e.g. lactate [25]. Previous
trials have produced mixed results in response to CM on
lactate acid. It seems exercise modality may have a bearing
on CMs ability to influence blood lactate concentrations.
Martinez-Sanchez et al. [29] for example found a reduc-
tion in lactate and an increase in lactate dehydrogenase,
responsible for converting lactate to pyruvate following
marathon running using a Watermelon CM drink con-
taining 3.45 g of citrulline. While, Kiyici et al. [5] reported
a reduction in lactate concentrations in handball players
immediately following exercise after supplementing with
4 g of CM 4 times per week for 4 weeks. In contrast Cun-
niffe et al. [20] found no effect of 12 g of CM on blood pH
or lactate following 10 sets of 15 s anaerobic sprints on a
cycle ergonometer. Likewise, a 6 g per day, 15 supplemen-
tation protocol of CM had no effect on muscle pH in pa-
tients suffering from fatigue following aerobic finger
flexion exercise [2]. Furthermore, in trials similar to this
one, Wax et al. [18], Wax et al. [19] and de Silva et al. [25]
all found no effect of 6 to 8 g of CM on lactate concen-
trations following resistance training exercise. While
Martinez-Sanchez et al. [29] reported no difference in
lactate dehydrogenase concentrations compared to pla-
cebo following half-squat exercises. Interestingly how-
ever Martinez-Sanchez et al. [29] did report a different
in plasma urea concentrations when citrulline was con-
sumed in combination with pomegranate extract high
in ellagitannins suggesting CM play some role in am-
monia metabolism, proteolysis and recovery.
The eccentric component of exercise is thought to be a
prominent factor in causing DOMS [31], despite employ-
ing a concentric only protocol, the GVT was effective in
increasing muscle soreness following the intervention.
The CM did not attenuate the muscle soreness and actu-
ally appeared to increase soreness. This lack of effect on
muscle soreness is in agreement with other investigations
[25], and in contrast to other investigations [17, 29].
Muscle soreness was also significantly reduced following
administration with citrulline infused watermelon drinks
following both a half marathon [29] and repeated sprints
on a cycloergonometer (32). The fact that soreness was re-
duced following both aerobic and anaerobic exercise trials
may make a case for CM being more effective in reducing
soreness across modalities. The lack of soreness seen in
this study is consistent with the fact we also found no dif-
ference in repetition performance, force loss, or lactate be-
tween the placebo and CM group. Presumably greater
muscle soreness would likely have been observed had
more repetitions been achieved from either group, al-
though CM is proposed to offset this soreness by
increased ammonium and lactate clearance. We however
did not measure ammonium concentrations but did note
a failure in CM to resist fatigue.
Chemical analysis of the CM product used in the study
suggested that the citrulline:malate composition ratio
was lower than that claimed by the manufacturer. The
present investigation therefore used a lower dose of cit-
rulline than we had intended administering (around
4.2 g instead of 5.3 g, based on a 2:1 ratio), this is still
higher than the dose contained in many pre-exercise
supplements and comparable doses administered in
other studies [18, 19]. The lack of significant findings
may therefore reflect a lower dosing of CM by compari-
son to other investigations. Interestingly citrulline has
been infused into watermelon in other trials [29, 32] and
appears to be more readily absorbed from a matrix of
watermelon compared to a functional drink. Many man-
ufacturers state the use of 2:1 formulas and it is unclear
how much citrulline was administered in other investiga-
tions as the CM ratios and chemical analysis is often un-
reported. Further investigations should therefore explore
the composition of the product being tested, as this may
influence measurements and outcomes. Citrulline has
been purported for its performance enhancing effect,
while malate has been cited to improve performance via
being an intermediate in the citric acid cycle. It seems
more likely that citrulline is the active ingredient as
malic acid is utilised to allow the supplement to form a
stable salt for storage and neutralise the basicity of
the supplement. This stability issue may be overcome by in-
fusion into a watermelon matrix. Performance-enhancing
effects have been found from using citrulline in isolation
[14] and researchers may wish to concentrate on using pure
citrulline, to avoid under dosed products.
Finally, given a number of trials suggesting a positive
effect of CM on anaerobic performance (for e.g.’s see
[19, 22]) further trials should be carried out utilising
both acute and loading doses of CM for both isokinetic
and multi joint protocols, using experienced resistance
trained populations. There were a number of limitations
of the present investigation include no measure of CK or
ammonia to accompany the data gathered on lactate and
muscle soreness. The subjects who participated in the
study were not a homogenous group, and subjects varied
in their training experience and included both men and
women not controlling for the impact of menstrual cyc-
ling; however all participants had at least six months
regular resistance training experience and are likely cus-
tomers for the supplement in question. We also did not
perform the experiment fasted, but subjects were
instructed to consume the same breakfast on both occa-
sions, however we did note no difference in 24 h dietary
intake between laboratory visits and point out that exer-
cisers are unlikely to perform in the fasted state. We also
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did not control or audit dietary supplements other than
asking subjects to not stop or begin supplement regimes
throughout the trial the rationale for this is that stopping
or starting a new supplement could either positively or
negatively affect performance. Furthermore, the isokin-
etic chair induces an eccentric and concentric force
which is not the same, for example, as a standard leg ex-
tension exercise performed in a commercial fitness facil-
ity; field studies with commonly used equipment and
exercises are needed to help answer questions over the
efficacy of CM. Additionally particular attention should
be paid to the chemical analysis of supplement content
carried out in the present paper, which raises concerns
over manufacturer’s claims. Athletes and coaches should
remain sceptical as to the efficacy of CM.
Conclusions
Citrulline malate supplementation is purported to im-
prove exercise performance and improve recovery. The
findings of this investigation failed to support this claim.
Previous studies however have managed to find positive
effects of CM supplementation on athletic performance,
although this may be limited to high intensity anaerobic
resistance training [17, 18]. The ability of CM to increase
arginine and potentially influence NOS, ammonia clear-
ance may remain valid, however the recent inconsistent
findings in the literature suggest CM ability to influence
the aforementioned factors may not result in marked
improvements for performance. Although the present
investigation adds evidence to the body of literature on
CM, further trials are required to test the efficacy of CM
supplementation in both acute and loading trials.
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